Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Payables (2018 - 2025)

Health Catalyst (HCAT) has disclosed Payables for 8 consecutive years, with $4.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Payables fell 65.38% year-over-year to $4.9 million, compared with a TTM value of $4.9 million through Sep 2025, down 65.38%, and an annual FY2024 reading of $11.4 million, up 72.16% over the prior year.
  • Payables was $4.9 million for Q3 2025 at Health Catalyst, down from $8.9 million in the prior quarter.
  • Across five years, Payables topped out at $14.3 million in Q3 2024 and bottomed at $4.4 million in Q4 2022.
  • Average Payables over 5 years is $7.2 million, with a median of $6.3 million recorded in 2023.
  • The sharpest move saw Payables soared 125.67% in 2024, then tumbled 65.38% in 2025.
  • Year by year, Payables stood at $4.7 million in 2021, then decreased by 5.73% to $4.4 million in 2022, then soared by 50.11% to $6.6 million in 2023, then soared by 72.16% to $11.4 million in 2024, then crashed by 56.77% to $4.9 million in 2025.
  • Business Quant data shows Payables for HCAT at $4.9 million in Q3 2025, $8.9 million in Q2 2025, and $8.9 million in Q1 2025.